ClinicalTrials.gov record
Completed Phase 2 Interventional

INDV-6001 Multiple-Dose Pharmacokinetic Study

ClinicalTrials.gov ID: NCT06576843

Public ClinicalTrials.gov record NCT06576843. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 12:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Multicentre Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Repeated Doses of INDV-6001 in Adults With Moderate to Severe Opioid Use Disorder

Study identification

NCT ID
NCT06576843
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Indivior Inc.
Industry
Enrollment
123 participants

Conditions and interventions

Interventions

  • INDV-6001 Drug
  • Sublocade Drug
  • Suboxone Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 16, 2024
Primary completion
Jan 20, 2026
Completion
Jan 20, 2026
Last update posted
Mar 15, 2026

2024 – 2026

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
Artemis Institute for Clinical Research San Diego California 92103
Innovative Clinical Research, Inc. Miami Lakes Florida 33016
Chicago Clinical Research Institute Inc. Chicago Illinois 60607
Precise Research Centers Flowood Mississippi 39232
Hassman Research Institute (Cenexel HRI - Marlton) Marlton New Jersey 08053
Richmond Behavioral Associates Staten Island New York 10314
Midwest Clinical Research Dayton Ohio 45417
Insite Clinical Research, LLC DeSoto Texas 75115
Memorial Hermann Village Houston Texas 77043
Pillar Clinical Research Richardson Texas 75080
Progressive Clinical Research Bountiful Utah 84010

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06576843, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 15, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06576843 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →